tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AZNCF Stock Latest News

AstraZeneca’s Phase 2 Study on Trastuzumab Deruxtecan: A Potential Game-Changer in Cancer Treatment
Company AnnouncementsAstraZeneca’s Phase 2 Study on Trastuzumab Deruxtecan: A Potential Game-Changer in Cancer Treatment
7h ago
AZN
AstraZeneca’s New Trial: A Step Forward in Liver Fibrosis Treatment?
PremiumCompany Announcements
AstraZeneca’s New Trial: A Step Forward in Liver Fibrosis Treatment?
7h ago
AZN
AstraZeneca’s Tozorakimab Study: A Potential Game-Changer in COPD Treatment
PremiumCompany Announcements
AstraZeneca’s Tozorakimab Study: A Potential Game-Changer in COPD Treatment
7h ago
AZN
AstraZeneca’s Phase 4 Study on Tezepelumab: A Boost for Severe Asthma Treatment
PremiumCompany Announcements
AstraZeneca’s Phase 4 Study on Tezepelumab: A Boost for Severe Asthma Treatment
7h ago
AZN
PRXL
AstraZeneca’s Tezepelumab Study: Potential Breakthrough in Asthma Treatment
PremiumCompany Announcements
AstraZeneca’s Tezepelumab Study: Potential Breakthrough in Asthma Treatment
7h ago
AZN
AstraZeneca’s Latest NSCLC Study Update: Key Insights for Investors
PremiumCompany AnnouncementsAstraZeneca’s Latest NSCLC Study Update: Key Insights for Investors
7h ago
AZN
AstraZeneca Announces $50 Billion Investment in US Manufacturing and R&D
Premium
Company Announcements
AstraZeneca Announces $50 Billion Investment in US Manufacturing and R&D
17h ago
AstraZeneca announces $50B of investment in U.S. by 2030
Premium
The Fly
AstraZeneca announces $50B of investment in U.S. by 2030
1d ago
AZN
AstraZeneca’s Observational SLE Study in Kazakhstan: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s Observational SLE Study in Kazakhstan: Key Insights for Investors
1d ago
AZN
AstraZeneca’s TRITON Study: A New Frontier in Lung Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s TRITON Study: A New Frontier in Lung Cancer Treatment
1d ago
AZN
AstraZeneca’s New Phase II Study: A Potential Breakthrough in Liver Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s New Phase II Study: A Potential Breakthrough in Liver Cancer Treatment
1d ago
AZN
AstraZeneca’s Promising Pediatric SLE Study: Anifrolumab’s Potential Impact
PremiumCompany Announcements
AstraZeneca’s Promising Pediatric SLE Study: Anifrolumab’s Potential Impact
1d ago
AZN
AstraZeneca’s Promising Study on Endometrial Cancer Treatment
PremiumCompany AnnouncementsAstraZeneca’s Promising Study on Endometrial Cancer Treatment
1d ago
AZN
AstraZeneca’s COPD Study: Potential Game-Changer for Cardiopulmonary Outcomes
Premium
Company Announcements
AstraZeneca’s COPD Study: Potential Game-Changer for Cardiopulmonary Outcomes
1d ago
AZN
AstraZeneca’s CORSAR Study: Unveiling Severe Asthma Insights in Russia
Premium
Company Announcements
AstraZeneca’s CORSAR Study: Unveiling Severe Asthma Insights in Russia
1d ago
AZN
AstraZeneca’s New Study on Saruparib: A Potential Game-Changer in Oncology?
PremiumCompany Announcements
AstraZeneca’s New Study on Saruparib: A Potential Game-Changer in Oncology?
1d ago
AZN
AstraZeneca’s AIRSUPRA Study: A Potential Game-Changer in Asthma Treatment
PremiumCompany Announcements
AstraZeneca’s AIRSUPRA Study: A Potential Game-Changer in Asthma Treatment
1d ago
AZN
AstraZeneca announces FLAURA2 study shows improvement in secondary endpoint
PremiumThe Fly
AstraZeneca announces FLAURA2 study shows improvement in secondary endpoint
1d ago
AZN
AstraZeneca announces OS analysis of FLAURA2 Phase III trial of Tagrisso
PremiumThe Fly
AstraZeneca announces OS analysis of FLAURA2 Phase III trial of Tagrisso
2d ago
AZN
AstraZeneca’s New Study on AZD4954: Potential Breakthrough in Cardiovascular Treatment
PremiumCompany AnnouncementsAstraZeneca’s New Study on AZD4954: Potential Breakthrough in Cardiovascular Treatment
4d ago
AZN
AstraZeneca’s New Trial on Benralizumab: A Potential Game-Changer for Pediatric Eosinophilic Diseases
Premium
Company Announcements
AstraZeneca’s New Trial on Benralizumab: A Potential Game-Changer for Pediatric Eosinophilic Diseases
4d ago
AZN
AstraZeneca’s AZD5004 Study: A New Hope for Type 2 Diabetes Treatment?
Premium
Company Announcements
AstraZeneca’s AZD5004 Study: A New Hope for Type 2 Diabetes Treatment?
4d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >